Related Image: The Obama Effect: New Job Trends to Watch in 2009 |
(Date:7/4/2009)... Even when budgets are tight, experts say, health...DAY, July 4 (HealthDay News) -- Most people are cu...o save more and make do with less. But can you cut...ns out, experts say you can -- if you,re smart abo...le still eating healthily, staying physically fit ...
(Date:7/3/2009)... , DEBRECEN, Hungary, July 3 Be...ltant, published a free e-guide for medical pr... be used in medicine. Medical conferences are expe...rlds for interaction. This eGuide helps doctors en...ions and meetings for free as Second Life provides...
(Date:7/3/2009)... , WASHINGTON, July 3 /PRNewswire-USNewswire/ -...pushing for language in health care reform legisla...rvices. If this happens, many women could lose cov...urance currently includes. Plus, millions of unins...vice despite having been promised a better quality...
(Date:7/3/2009)... , ReverseAges.com launch...lood pressure, adrenal fatigue, and how to best de... San Diego, CA (PRWEB) July 3, 2009 -- Revers...ges. These pages explain the dangers of common hea... pressure is caused by a variety of factors, and t...
Breaking Medicine News(10 mins):Health News:Living Healthily on Less 2Health News:Living Healthily on Less 3Health News:Living Healthily on Less 4...no sunscreen in spite of staying under direct sunl...ate in outdoor sports spend a significant amount o... often during peak hours. Because they are spendin...igh risk for developing skin cancer, yet few of th...
...close association to fishes has been proven to inh... of omega 3 fatty acids such as docosahexaenoic ac...urb the growth of breast cancer cells, according t...ternational Journal of Cancer. Min Wu and colleagu...
...a nationwide study in USA to see if the procedures... hospitals. The study will enroll of more than 16...angioplasty //can be safely performed in smaller, ...the therapy for patients. Researchers expect to en...
...diseases all around the world. Researchers have no...ering adult diabetics an alternative to injections...yet to be approved by the FDA. If approved, the dr...to the insulin injections taken by millions worldw...
Other Medicine News:Health News:People Still Neglect To Use Sunscreen In Spite Of Cancer Warnings 2Health News:Exubera could mean the end of an insulin injection era for diabetics 2(Date:6/30/2009)... SAN DIEGO, June 30 Accumetrics, I... (1,600 patients) in the enrollment of its landmar...ness with A V erifyNow(R) Assay I mpact on T hr...y designed to demonstrate the value of providing c... who are poor responders to clopidogrel (Plavix(R)...
(Date:6/29/2009)... ROCHESTER, Minn., June 29 /PRNewswire-USNewswire/...the effectiveness of deep brain stimulation (DBS...ive disorder (OCD) and Tourette,s syndrome are und..., according to a review in the June 2009 issue of ...lation has long been seen as valuable for controll...
(Date:6/28/2009)... S. MAMEDE DO CORONADO, Portugal, June 29 /PRN...monstrated that add-on treatment with the novel,...pine acetate; ESL) resulted,in a marked and susta...erm(1). , Results from the one-year extensi... study were presented at the International Congres...
(Date:6/26/2009)... --Combination of Inherited and New Genetic Mutati... More pieces in the com... latest study from a research team including genet...a, the University of Pennsylvania School of Medi...study identified 27 different genetic regions wher...
Breaking Medicine Technology:Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7More Gene Mutations Linked to Autism Risk 2More Gene Mutations Linked to Autism Risk 3More Gene Mutations Linked to Autism Risk 4New class of RNA molecules may be important in human cancer 960 1New class of RNA molecules may be important in human cancer 960 2Was ability to run early mans Achilles heel 3F 338 1Was ability to run early mans Achilles heel 3F 338 2Was ability to run early mans Achilles heel 3F 338 3Experts Offer Tips on Lung Cancer Prevention 959 1Experts Offer Tips on Lung Cancer Prevention 959 2Experts Offer Tips on Lung Cancer Prevention 959 36 Years Later 9 11 Health Questions Linger 957 16 Years Later 9 11 Health Questions Linger 957 26 Years Later 9 11 Health Questions Linger 957 36 Years Later 9 11 Health Questions Linger 957 46 Years Later 9 11 Health Questions Linger 957 5...& CEO of the Lupus,Foundation of America, Inc..../ -- The Lupus,Foundation of America, Inc. and mor...awaiting the preliminary findings of the Phase,III...tment for,lupus kidney disease being tested by Asp...eatments for lupus patients is,critical because ma...
...linical Trial in Type 2,Diabetes Patients Announce... Transition,Therapeutics Inc. ("Transition") , tod...e IIa clinical trial indicating that 4-weeks of,da...T.(TM), showed,sustained reductions in blood gluco...bA1c), for 6 months post-treatment. The type 2,dia...
Other Medicine Technology:Lupus Foundation of America Statement on Results for Clinical Study,of CellCept Released by Aspreva Pharmaceutical Company 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 4A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 512 mm angled tip with gently curved blade. Short hexagonal handle with polished finish.
0.5 mm x 15 mm angled round blade with smoothly pointed tip and gently curved blade. Round knurled handle with polished finish.
Double ended with 0.5 mm by 10 mm and 0.5 mm by 15 mm blades. Both ends are sharp with gently curved blades. Square serrated handle with polished finish. Most popular size or model.
0.5 mm short 90 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm.
Medicine Products: